title: Mutant p53 protein in the serum of patients with colorectal cancer: Correlation with the level of carcinoembryonic antigen and serum epidermal growth factor receptor.
abstract: BACKGROUND
  Enzyme-linked immunosorbent assay (ELISA) was used for analysis of serum mutant p53 protein, carcinoembryonic antigen (CEA), and epidermal growth factor receptor (EGFR). Serum samples were obtained from 48 patients with colorectal cancer (CRC) and a control group of twenty healthy individuals.
  
  
  RESULTS
  The results demonstrated a significant increase of serum mutant p53, EGFR, and CEA levels in CRC patients compared to the control group (P<0.001 for each). Mutant p53 protein was significantly different in the different CRC grades (P=0.028). p53, CEA, and EGFR can differentiate successfully between different CRC grades and normal control (P<0.001 for each). Sensitivities of p53, CEA, and EGFR were 39.6, 31, and 71%, respectively. There was no correlation between CEA, EGFR, and p53 indicating that these variables were independent. Positive status of serum CEA and (or) p53 was found in 29 out of 48 (60%) patients. Also, positive status of serum CEA and (or) EGFR was found in 39 out of 48 (81%) patients.
  
  
  CONCLUSIONS
  Thus, the simultaneous determination of p53 or EGFR combined with the CEA may increase the sensitivity to diagnose CRC patients and may aid in disease prognosis.
authors.affiliation: Biotechnology Research Laboratories Division, Gastro-Entrology Surgery Center, Mansoura University, Mansoura, Egypt.
authors.forename: Mohamed M
authors.initials: MM
authors.lastname: Abdel-Aziz
authors.forename: Mahmoud
authors.initials: M
authors.lastname: Lotfy
authors.forename: Ibrahim M
authors.initials: IM
authors.lastname: El-Kady
authors.forename: Mostafa
authors.initials: M
authors.lastname: Abozaid
mesh_terms: D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor / Q000097:blood*; D002272:Carcinoembryonic Antigen / Q000097:blood*; D016022:Case-Control Studies; D015179:Colorectal Neoplasms / Q000097:blood* / Q000175:diagnosis / Q000473:pathology; D066246:ErbB Receptors / Q000097:blood*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D050505:Mutant Proteins / Q000097:blood*; D009367:Neoplasm Staging; D012372:ROC Curve; D012680:Sensitivity and Specificity; D016159:Tumor Suppressor Protein p53 / Q000097:blood*; D055815:Young Adult
chemical_list: D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen; D050505:Mutant Proteins; D016159:Tumor Suppressor Protein p53; D066246:ErbB Receptors